Across TCGA pan-cancer cohorts, NTM-IT RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of NTM-IT’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where NTM-IT RNA is repressed in tumor relative to normal tissue. In most cancer types NTM-IT is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.
LUSC and HNSC are the cancer types where NTM-IT tumor–normal differential expression is most reproducible.